Yingye Zheng

No ORCID on file · 1 paper in corpus
diagnostic-accuracy 2010
Clinical biochemistry ·doi:10.1016/j.clinbiochem.2009.10.012

OBJECTIVES: New ovarian cancer biomarkers suitable for early disease diagnosis, prognosis or monitoring could improve patient management and outcomes. DESIGN AND METHODS: Nidogen-2 was measured by immunoassay in serum of 100 healthy women,…